Valencell v. Fitbit: Biometric Sensor Patents Dismissed With Prejudice After 8+ Years
Valencell, Inc. sued Fitbit, Inc. in the Eastern District of North Carolina in January 2016, asserting four patents covering wearable biometric sensing technology against the Fitbit Charge HR and Surge. After 3,062 days of litigation — one of the longer district court patent proceedings on record — the parties stipulated to dismiss all claims with prejudice in May 2024.
Eight years of biometric IP conflict ends in mutual stipulated exit
On 4 January 2016, Valencell, Inc. — a North Carolina-based biometric sensing IP company — filed suit against Fitbit, Inc. and Fitbit, LLC in the Eastern District of North Carolina (Case No. 5:16-cv-00002), alleging infringement of four patents covering wearable physiological monitoring technology. The accused products were the Fitbit Charge HR and Surge, two of Fitbit’s most commercially prominent fitness trackers at the time. The case was assigned to Judge James C. Dever, III.
On 23 May 2024, the parties filed a joint stipulation of dismissal. Under its terms, Valencell’s infringement claims were dismissed with prejudice — permanently extinguishing Valencell’s right to re-assert those claims against Fitbit. Fitbit’s counterclaim for patent infringement (Count I) was dismissed without prejudice, preserving Fitbit’s optionality on that specific claim. Fitbit’s declaratory relief counterclaims (Counts II–IX) were dismissed with prejudice, closing those issues permanently for both parties.
A case running 3,062 days — more than eight years — is exceptionally long for a district court patent action and suggests the dispute was fiercely contested, likely surviving multiple IPR petitions, claim construction battles, and potentially appellate detours before reaching resolution. The public record does not disclose financial settlement terms, royalty obligations, or whether a licensing arrangement underpins the stipulation. The permanent bar on Valencell’s claims, combined with the preservation of Fitbit’s infringement counterclaim, suggests the settlement dynamics, if any, favoured Fitbit’s position.
Filing to Dismissed with Prejudice in 3062 days
8.4 years litigated — well above the median patent case duration of 2–3 years
Stipulated dismissal with prejudice: what the agreed terms mean for each party
Dismissed with prejudice: Valencell’s claims are permanently barred
A dismissal with prejudice is a final adjudication on the merits for procedural purposes. Valencell cannot re-file these infringement claims against Fitbit for the same patents and accused products. The stipulated nature — agreed by both parties — means neither side received a court finding of infringement or invalidity, but Valencell’s enforcement path is definitively closed as to these asserted patents.
Rule 41 stipulated dismissalValencell forfeits all four patent claims against Fitbit permanently
Valencell’s four biometric sensor patents — US8989830B2, US8923941B2, US8886269B2, and US8929965B2 — can no longer be enforced against Fitbit in any new action arising from the same accused products. Whether Valencell received any financial consideration or licensing concessions in exchange for this permanent relinquishment is not disclosed in the public record. The outcome suggests Valencell’s litigation position may have weakened materially over the 8+ year period.
No re-filing permittedFitbit preserves its own infringement counterclaim for future use
Fitbit’s declaratory relief counterclaims (Counts II–IX) are also dismissed with prejudice, closing those legal questions. However, Fitbit’s own patent infringement counterclaim (Count I) was dismissed without prejudice — a deliberate carve-out that preserves Fitbit’s right to assert that claim independently if it chooses. This asymmetry is notable and consistent with Fitbit negotiating from a position of relative strength at settlement.
Fitbit counterclaim preservedWearable biometric IP: enforcement risk for these patents substantially reduced
The permanent disposal of Valencell’s four sensor patents against Fitbit removes a meaningful cloud over the Charge HR and Surge product lines. For other wearable device makers who may have monitored this case as a bellwether for biometric sensor IP exposure, the outcome — without a merits finding — provides limited legal precedent on claim validity or infringement scope. Third parties should conduct independent FTO analysis rather than relying on this outcome as validation of design freedom.
No merits precedent setFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Valencell, Inc. | Company | Biometric sensing IP licensor — holder of US8989830B2 and three related wearable sensor patentsSearch in Eureka ↗ |
| Defendant | Fitbit, Inc. | Company | Consumer wearable fitness tracker manufacturer; maker of the Charge HR and Surge devicesSearch in Eureka ↗ |
| Co-Defendant | Fitbit, LLC | Company | Search in Eureka ↗ |
| Plaintiff counsel | Brian P. Herrmann | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Christopher T. Graebe | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Gavin B. Parsons | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | James Robert Perkins | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jeffrey R. Bragalone | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jerry D Tice | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jonathan H. Rastegar | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Justin B. Kimble | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Lynne A. Borchers | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Patrick J. Conroy | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Peter D. Siddoway | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Thomas William Kennedy , Jr. | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff counsel | William Gabriel Pagan | Attorney | Counsel for Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Bragalone Conroy PC | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Bragalone Olejko Saad PC | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Coats & Bennett PLLC | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Morningstar Law Group | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Nelson Bumgardner Albritton PC | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Sage Patent Group | Law Firm | Representing Valencell, Inc.Search in Eureka ↗ |
| Defendant counsel | Andrew Robert Shores | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Catherine Rose Lacey | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Edward John DeFranco | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Grant N. Margeson | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Kevin P.B. Johnson | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Mark Yeh-Kai Tung | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Michael B. Bruns | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Robert C. Van Arnam | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Sam Stephen Stake | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant counsel | Victoria Fishman Maroulis | Attorney | Counsel for Fitbit, Inc.Search in Eureka ↗ |
| Defendant law firm | Quinn Emanuel Urquhart & Sullivan, LLP | Law Firm | Representing Fitbit, Inc.Search in Eureka ↗ |
| Defendant law firm | Williams Mullen PC | Law Firm | Representing Fitbit, Inc.Search in Eureka ↗ |
| Presiding judge | Judge James C. Dever, III | Judge | North Carolina Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulated dismissal is structured with surgical precision: Valencell’s claims die permanently; Fitbit’s declaratory counterclaims (Counts II–IX) are likewise closed with prejudice; but Fitbit’s infringement counterclaim (Count I) survives without prejudice. This asymmetry is legally significant — it suggests Fitbit’s counsel negotiated a deliberate preservation of offensive patent rights while eliminating the declaratory cloud. No court made findings on infringement, validity, or claim scope, meaning this verdict text creates no binding legal precedent on the substantive patent issues.
US8989830B2 and three co-asserted biometric sensor patents
The four patents asserted — US8989830B2, US8923941B2, US8886269B2, and US8929965B2 — originate from application filings in the 2013–2014 window, covering wearable biometric monitoring technology. Valencell’s patent family is understood to encompass methods and apparatus for measuring physiological parameters such as heart rate and activity metrics through optical sensors integrated into wearable form factors — precisely the core technology enabling devices like the Fitbit Charge HR and Surge to deliver continuous biometric feedback. The patents sit at the intersection of photoplethysmography (PPG) sensing, signal processing, and wearable industrial design.
Valencell positioned itself as a foundational IP licensor in the biometric wearables space, with a portfolio that predates the mass-market fitness tracker boom. These four patents represent a strategic assertion against one of the segment’s dominant players at a time when wrist-worn heart rate monitoring was a key commercial differentiator. For competitors developing optical biometric wearables — including smartwatch makers, medical-grade monitors, and sports performance devices — Valencell’s patent family represents a meaningful design-around and FTO consideration, independent of this case’s outcome against Fitbit.
Should your product team run an FTO against US8989830B2 and Valencell’s sensor patents?
Any R&D or product team developing wrist-worn or body-worn devices that use optical sensors to measure heart rate, SpO2, or related physiological parameters should treat the Valencell biometric patent family as a live FTO risk. The dismissal in this case is specific to Fitbit and creates no finding of invalidity or non-infringement. Valencell retains the right to assert these patents — and potentially related continuation patents — against other parties in the wearable sensor market.
PatSnap Eureka’s FTO Search Agent enables product and IP teams to map claim scope across US8989830B2, US8923941B2, US8886269B2, and US8929965B2 against your specific device architecture. Eureka can surface continuation and continuation-in-part filings from the same Valencell priority chains, identify PTAB proceedings that may have narrowed or invalidated claims, and flag design-around prior art — giving your team a defensible clearance position before product launch or market entry.
Run a freedom-to-operate analysis on US8989830B2 to assess your product’s exposure
Run FTO in Eureka →Similar wearable biometric sensor patent cases in U.S. district courts
Cases involving optical biometric sensing and wearable physiological monitoring patents in U.S. district courts, with comparable infringement claims against consumer wearable device makers.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable The Charge HR and Surge-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedValencell, Inc.’s broader IP enforcement history
Valencell, Inc.’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the wearable biometric IP landscape
An 8+ year biometric sensor dispute ending in stipulated dismissal carries clear signals for IP strategy in the wearables sector.
Long patent battles without merits rulings leave the IP landscape uncertain
After 3,062 days, no court found these four Valencell patents valid or invalid, infringed or not infringed. Competitors in wearable biometrics cannot treat this outcome as clearing the field. The patents remain issued and, outside of Fitbit, are potentially enforceable against other parties. Independent FTO analysis against US8989830B2 and its co-asserted patents remains essential for any wrist-worn physiological sensor product.
Asymmetric dismissal terms signal negotiating leverage — study them carefully
The decision to dismiss Fitbit’s infringement counterclaim (Count I) without prejudice while closing everything else with prejudice is a deliberate structural choice. IP teams monitoring wearable sensor litigation should note this as a signal that Fitbit retained optionality. Any company in commercial relationship with Fitbit or competing in overlapping product segments should assess exposure to that preserved counterclaim.
Valencell’s patent portfolio beyond these four patents: what remains live
This dismissal extinguishes only the four asserted patents as against Fitbit. Valencell may hold additional biometric and photoplethysmography patents not at issue in this case. Companies developing optical heart rate sensing, SpO2 monitoring, or continuous biometric wearables should map Valencell’s full portfolio — not just the litigated subset — before product launch or investment.
Eight-year duration suggests parallel IPR activity — check PTAB history before relying on these patents
Cases of this duration frequently involve USPTO Patent Trial and Appeal Board proceedings running concurrently with district court litigation. If IPR petitions were filed against any of the four Valencell patents, those proceedings may have issued final written decisions affecting claim scope. Patent teams should audit PTAB records for US8989830B2, US8923941B2, US8886269B2, and US8929965B2 before any licensing or design-around decision.
Valencell v Fitbit — key questions answered
The case was dismissed with prejudice by stipulation of the parties on 23 May 2024. Valencell’s four-patent infringement claims against Fitbit are permanently barred. Fitbit’s declaratory counterclaims (Counts II–IX) were also dismissed with prejudice, while Fitbit’s infringement counterclaim (Count I) was dismissed without prejudice, preserving Fitbit’s right to assert it in future proceedings.
Valencell asserted four patents: US8989830B2, US8923941B2, US8886269B2, and US8929965B2. All four relate to wearable biometric sensing technology and were filed via applications in the 2013–2014 period. They were asserted against the Fitbit Charge HR and Surge fitness tracking devices.
The case ran for 3,062 days from filing in January 2016 to closure in May 2024. While the public record does not fully explain the delay, cases of this length typically involve parallel USPTO inter partes review proceedings, multiple claim construction hearings, extensive discovery, and potentially appeals — all of which can extend district court litigation significantly.
No. A dismissal with prejudice by stipulation carries no finding on the merits of validity or infringement. The patents remain issued and are potentially enforceable against third parties. Companies in the wearable biometric sensing space should not treat this outcome as a validity determination and should conduct independent FTO analysis before relying on design freedom.
Fitbit’s patent infringement counterclaim (Count I) was dismissed without prejudice — meaning Fitbit retains the right to assert that claim independently in future litigation. This contrasts with all other claims, which were closed permanently. The asymmetry suggests the parties negotiated this carve-out deliberately, and it may signal that Fitbit holds its own offensive patent rights over technology relevant to Valencell or the broader wearables space.
Map your FTO risk against Valencell’s wearable biometric sensor patents
The four Valencell patents remain issued and potentially enforceable against third parties. Use PatSnap Eureka to run claim-level FTO analysis and monitor Valencell’s patent portfolio activity before your next product launch.
PatSnap Eureka searches patents and litigation data to answer instantly.